Eric Boersma
Thoraxcenter
University Hospital Rotterdam
Netherlands
Name/email consistency: high
- Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Boersma, E., Harrington, R.A., Moliterno, D.J., White, H., Théroux, P., Van de Werf, F., de Torbal, A., Armstrong, P.W., Wallentin, L.C., Wilcox, R.G., Simes, J., Califf, R.M., Topol, E.J., Simoons, M.L. Lancet (2002)
- Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Boersma, E., Pieper, K.S., Steyerberg, E.W., Wilcox, R.G., Chang, W.C., Lee, K.L., Akkerhuis, K.M., Harrington, R.A., Deckers, J.W., Armstrong, P.W., Lincoff, A.M., Califf, R.M., Topol, E.J., Simoons, M.L. Circulation (2000)
- Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention. Boersma, E., Akkerhuis, K.M., Théroux, P., Califf, R.M., Topol, E.J., Simoons, M.L. Circulation (1999)